{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:29:51Z","timestamp":1791163791831,"version":"4.1.0"},"reference-count":48,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T00:00:00Z","timestamp":1245628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cellular interactions between activated microglia and degenerating neurons in<jats:italic>in vivo<\/jats:italic>models of Parkinson\u2019s disease are not well defined. This time course study assesses the dynamics of morphological and immunophenotypic properties of activated microglia in a 6\u2010hydroxydopamine (6\u2010OHDA) model of Parkinson\u2019s disease. Neurodegeneration in the substantia nigra pars compacta (SNc) was induced by unilateral injection of 6\u2010OHDA into the medial forebrain bundle. Activated microglia, identified using monoclonal antibodies: clone of antibody that detects major histocompatibility complex (MHC) class II antigens (OX6) for MHC class II, clone of antibody that detects cell surface antigen\u2010cluster of differentiation 11b \u2013 anti\u2010complement receptor 3, a marker for complement receptor 3 and CD 68 for phagocytic activity. Activation of microglia in the lesioned SNc was rapid with cells possessing amoeboid or ramified morphology appeared on day 1, whilst antibody clone that detects macrophage\u2010myeloid associated antigen immunoreactivity was observed at day 3 post\u2010lesion when there was no apparent loss of tyrosine hydroxylase (TH)+ve dopaminergic (DA) SNc neurons. Thereafter, OX6 and antibody clone that detects macrophage\u2010myeloid associated antigen activated microglia selectively adhered to degenerating axons, dendrites and apoptotic (caspase 3+ve) DA neurons in the SNc were observed at day 7. This was followed by progressive loss of TH+ve SNc neurons, with the peak of TH+ve cell loss (51%) being observed at day 9. This study suggests that activation of microglia precedes DA neuronal cell loss and neurons undergoing degeneration may be phagocytosed prematurely by phagocytic microglia.<\/jats:p>","DOI":"10.1111\/j.1471-4159.2009.06189.x","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T17:19:29Z","timestamp":1245691169000},"page":"966-975","source":"Crossref","is-referenced-by-count":197,"title":["Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6\u2010hydroxydopamine model of Parkinson\u2019s disease"],"prefix":"10.1111","volume":"110","author":[{"given":"Lilia","family":"Marinova\u2010Mutafchieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Broom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Medhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Dexter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,7,13]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)91447-8"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490380402"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)90835-J"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025024129946"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20265"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2002.01938.x"},{"key":"e_1_2_7_9_1","first-page":"140","article-title":"Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1","volume":"83","author":"Damoiseaux J. G.","year":"1994","journal-title":"Immunology"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0353-x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199603000-00001"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00928.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-5234fje"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490210104"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1998.00379.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-004-0121-3"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0211638"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(01)00562-0"},{"key":"e_1_2_7_20_1","first-page":"333","article-title":"Activation and re\u2010expression of surface antigen in microglia following an epidural application of kainic acid in the rat brain","volume":"180","author":"Kaur C.","year":"1992","journal-title":"J. Anat."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1006\/mcne.2000.0914"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(96)10049-7"},{"key":"e_1_2_7_24_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-1999-1289","article-title":"MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson\u2019s disease","volume":"59","author":"Kurkowska\u2010Jastrzebska I.","year":"1999","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.6361"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4303-03.2004"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00689592"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.08.008"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.04705.x"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-4882fje"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5400.401"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1515\/REVNEURO.2002.13.3.221"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20467"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00471-9"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90096-7"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2007.07.024"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.04699.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/35037722"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007048903862"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-5748(00)00063-0"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001809"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-5106com"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902680209"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)04085-4"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(96)00545-3"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2005.04362.x"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2009.06189.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2009.06189.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T20:12:06Z","timestamp":1710447126000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2009.06189.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,13]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1471-4159.2009.06189.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06189.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,13]]}}}